Celyad
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
63 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
January 20, 2016 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Celyad by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 13, 2018 | Armistice Capital LLC | 1.10% | August 28, 2018 |
| August 1, 2018 | Armistice Capital LLC | 1.00% | August 13, 2018 |
| June 18, 2018 | Armistice Capital LLC | 0.90% | August 1, 2018 |
| May 18, 2018 | Armistice Capital LLC | 0.81% | June 18, 2018 |
| May 17, 2018 | Armistice Capital LLC | 0.65% | May 18, 2018 |
| October 13, 2017 | Voleon Capital Management LP | 0.51% | October 17, 2017 |
| March 1, 2017 | GSA Capital Partners LLP | 0.59% | June 8, 2017 |
| February 24, 2017 | GSA Capital Partners LLP | 0.61% | March 1, 2017 |
| February 22, 2017 | GSA Capital Partners LLP | 0.59% | February 24, 2017 |
| October 26, 2016 | GSA Capital Partners LLP | 0.61% | February 22, 2017 |
| August 15, 2016 | GSA Capital Partners LLP | 0.50% | October 26, 2016 |
| March 14, 2016 | GSA Capital Partners LLP | 0.50% | March 23, 2016 |
| January 20, 2016 | GSA Capital Partners LLP | 0.50% | March 11, 2016 |
Download 63 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Belgium
- Solvay 1.39% of the capital sold short
- Umicore 1.20% of the capital sold short
- EVS 0.89% of the capital sold short
- D'Ieteren Group 0.79% of the capital sold short
- Syensqo 0.79% of the capital sold short
- Azelis 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- Montea 0.58% of the capital sold short
- Melexis 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Celyad, source FSMA, data as at October 11, 2021, https://www.quivad.com/action/celyad?page=2